Journal of clinical practice,
Год журнала:
2024,
Номер
unknown
Опубликована: Дек. 20, 2024
Lung-on-a-Chip
(LoC)
is
a
microfluidic
device
that
simulates
the
gas-liquid
interface
of
human
pulmonary
alveoli
and
intended
for
pathophysiological,
pharmacological
molecular
biological
studies
blood-air
barrier
in
vitro.
The
LoC
includes
system
liquid
gas
microchannels
separated
by
semipermeable
elastic
membrane
containing
polymer
base
cellular
elements
alveoli.
Depending
on
type
(single-channel,
two-channel
three-channel),
may
contain
only
alveolocytes,
or
alveolocytes
combination
with
other
cells:
endothelial
cells,
fibroblasts,
alveolar
macrophages,
tumor
etc.
Some
models
also
include
hydrogel
stroma
interstitium.
first
LoC,
which
there
monolayer
cells
one
side
other,
was
developed
2010
group
Ingber
et
al.
at
Wyss
Institute
Harvard
University
order
to
reproduce
microenvironment
biomechanics
Modern
modifications
same
differ
design
system,
biomaterial,
composition
stromal
special
tasks
being
solved.
In
addition
barrier,
are
studying
specific
pathophysiological
processes,
screening
drugs,
modeling
particular
diseases,
such
as
lung
cancer,
COPD
asthma.
this
review,
we
analyzed
existing
varieties
biomaterials
used,
methods
detecting
processes
devices
main
areas
research
using
"Lung-on-a-chip"
technology.
Scientific Reports,
Год журнала:
2024,
Номер
14(1)
Опубликована: Ноя. 1, 2024
Airway
inflammation,
a
protective
response
in
the
human
body,
can
disrupt
normal
organ
function
when
chronic,
as
seen
chronic
obstructive
pulmonary
disease
(COPD)
and
asthma.
Chronic
bronchitis
induces
goblet
cell
hyperplasia
metaplasia,
obstructing
airflow.
Traditional
animal
testing
is
often
replaced
by
vitro
three-dimensional
cultures
of
epithelial
cells
to
assess
responses.
However,
these
are
cultured
horizontally,
differing
from
tubular
structure
airway
failing
accurately
reproduce
stenosis.
To
address
this,
we
developed
Bronchus-on-a-Chip
(BoC)
system.
The
BoC
uses
novel
microfluidic
design
standard
laboratory
plate,
embedding
62
chips
one
plate.
Human
bronchial
were
against
collagen
extracellular
matrix
for
up
35
days.
Characterization
included
barrier
integrity
assays,
microscopy,
histological
examination.
Cells
successfully
structure,
with
apical
side
air-lifted.
Epithelial
differentiated
into
basal,
ciliated,
secretory
cells,
mimicking
epithelium.
Upon
exposure
inducers
system
showed
mucus
hyperproduction,
replicating
This
enhances
providing
more
human-relevant
high-throughput
method.
Research Square (Research Square),
Год журнала:
2024,
Номер
unknown
Опубликована: Янв. 8, 2024
AbstractBoswellia
carterii
(BC)
resins
plants
have
a
long
historical
background
as
treatment
for
inflammation,
indicated
by
information
originating
from
multiple
countries.
Twenty-seven
diterpenoids
been
identified
in
ethylacetate
and
total
methanol
BC,
comprising
seventeen
boscartins
of
the
cembrane-type
ten
boscartols
prenylaromadendrane-type
diterpenoids.
Moreover,
twenty-one
known
triterpenoids
also
found,
encompassing
nine
tirucallane-type,
six
ursane-type,
four
oleanane-type,
two
lupane-type.
The
hold
significant
position
pharmaceutical
chemistry
related
industries
due
to
their
captivating
biological
characteristics
promising
pharmacological
potentials.
Extraction
creation
assessment
nano
sponges
loaded
with
either
B.
Carterii
plant
extract
or
DEX,
are
subjects
our
current
investigation.
With
use
ultrasound-assisted
synthesis,
were
produced.
entrapment
efficiency
(EE%)
medications
Nano
was
examined
using
spectrophotometry.
characterized
number
methods.
Within
sponges,
EE%
medicines
varied
between
98.52±
0.07
99.64±
1.40%.
sponges'
particle
sizes
105.9±15.9
166.8±26.3
nm.
Drugs
released
Korsmeyer-Peppas
concept.
In
respiratory
distressed
rats,
effects
BC
extract,
DEX
salt
formulations
(D1,
D5,
P1
P1),
tested.
Treatment
significantly
reduced
ICAM-1,
LTB4,
ILβ4
levels
improved
histopathologic
profiles,
when
compared
positive
control
group.
Boswellia
its
sponge
formulation
showed
therapeutic
effects.
effect
may
be
synergism
both
formulation.
This
achieved
blocking
ICAM-1
LTB4
pathways,
therefore
counteracting
talc
powder.
Journal of Tissue Engineering,
Год журнала:
2024,
Номер
15
Опубликована: Янв. 1, 2024
Tissue
engineering
and
in
vitro
modeling
of
the
airways
lungs
respiratory
system
are
substantial
research
clinical
importance.
In
airway
lung
models
aim
to
improve
treatment
options
for
repair
advance
pathophysiological
research.
The
construction
biomimetic
native
with
tissue-specific
biological,
mechanical,
configurable
features
remains
challenging.
Bioprinting,
an
emerging
3D
printing
technology,
is
promising
development
airway,
lung,
disease
models,
allowing
incorporation
cells
biologically
active
molecules
into
printed
constructs
a
precise
reproducible
manner
recreate
airways,
architecture,
microenvironment.
Herein,
we
present
review
bioprinting
applications
tissue
modeling.
key
characteristics
interstitium,
alveoli
described.
bioinks
recently
used
summarized.
Furthermore,
propose
bioink
categorization
based
on
structural
airways.
Finally,
challenges
opportunities
biofabrication
discussed.
Journal of clinical practice,
Год журнала:
2024,
Номер
unknown
Опубликована: Дек. 20, 2024
Lung-on-a-Chip
(LoC)
is
a
microfluidic
device
that
simulates
the
gas-liquid
interface
of
human
pulmonary
alveoli
and
intended
for
pathophysiological,
pharmacological
molecular
biological
studies
blood-air
barrier
in
vitro.
The
LoC
includes
system
liquid
gas
microchannels
separated
by
semipermeable
elastic
membrane
containing
polymer
base
cellular
elements
alveoli.
Depending
on
type
(single-channel,
two-channel
three-channel),
may
contain
only
alveolocytes,
or
alveolocytes
combination
with
other
cells:
endothelial
cells,
fibroblasts,
alveolar
macrophages,
tumor
etc.
Some
models
also
include
hydrogel
stroma
interstitium.
first
LoC,
which
there
monolayer
cells
one
side
other,
was
developed
2010
group
Ingber
et
al.
at
Wyss
Institute
Harvard
University
order
to
reproduce
microenvironment
biomechanics
Modern
modifications
same
differ
design
system,
biomaterial,
composition
stromal
special
tasks
being
solved.
In
addition
barrier,
are
studying
specific
pathophysiological
processes,
screening
drugs,
modeling
particular
diseases,
such
as
lung
cancer,
COPD
asthma.
this
review,
we
analyzed
existing
varieties
biomaterials
used,
methods
detecting
processes
devices
main
areas
research
using
"Lung-on-a-chip"
technology.